INBREEDING IS THE MAIN CAUSE OF RARE DISEASES IN TURKEY

.
.
WHAT  IS THE MAIN CAUSE OF RARE DISEASES IN TURKEY

Turkey Medicals member and Hospital Pediatric Hematology and Genetics Specialist Prof. Dr., inbreeding is the reason for the high level of rare diseases in Turkey, stating, “about 5 million people are affected by this situation,” he said.

A specialist in children’s blood and genetic diseases in Antalya, Professor Dr. on World Rare Diseases Day made statements on the occasion.

Prof. Dr. Rare diseases, a highly mixed group of diseases that affect multiple systems, often occur as a result of mutations in chromosomes or genes, said. There are more than 7 thousand rare diseases in the world. Dr. noted that 1 person out of every 15 people in the world is affected by Rare Diseases.

.
400 MILLION PEOPLE WORLDWIDE AFFECTED

Prof. Dr., “around 400 million people in the world are affected by rare diseases, while 30 million people in Europe and 25 million people in America are affected. In Turkey, rare diseases are 6-8 percent, while the main reason for the high rate is the excess of inbreeding. Cross-cultural transition, we are in a position that has united all continents for many years. For him, many diseases appear in this region. Plus inbreeding in our country 25 percent, that is, one out of every 4 people inbreeding rare diseases are very high in our country. About 5 million people are affected. In this respect, inbreeding needs to be reduced. For this reason, we recommend that young people be screened for diseases before marriage and before pregnancy. A second important issue is that families are healthy. For this, parents must be screened for rare diseases,” he said.

.
95 PERCENT HAVE NOT YET FOUND A CURE

95 percent of rare diseases do not yet have a treatment noted Prof. Dr. “75 percent children are affected. 30 percent of people with rare diseases die before the age of 5,” he said. Families with sick children should be made clear definitions by exon and genome analysis. Dr., currently close to 332 genes are being analyzed before pregnancy. In this way, the birth of a sick child can be prevented. After the diagnosis of both the child and the parents of a family with a rare disease is clear by performing all exome, genome tests, we recommend the method of in vitro fertilization by extracting the gene to have a healthy child,” he said.

.
CORD TIE MUST BE STORED

Stem cells are used in any future disease by hiding the umbilical cord of the newborn child. Dr., “cord bond with the umbilical cord, blood is stored in the child himself and family members in the event of any disease in the future there are stem cells used. In the umbilical cord blood of a child born with this method, the sick brother is treated, and the Turkish family saves the sick child and has a healthy child in Turkey. Today, many centers in our country do this, but families need to be guaranteed that it will be stored for a long time,” he said.
.
.
.

Follow me
President of Organ Transplant Center at MedicalPark Hospital Antalya

Turkey's world-renowned organ transplant specialist. Dr. Demirbaş has 104 international publications and 102 national publications.

Physician's Resume:

Born on August 7, 1963 in Çorum, Prof. Dr. Alper Demirbaş has been continuing his work as the President of MedicalPark Antalya Hospital Organ Transplantation Center since 2008.

Prof. who performed the first tissue incompatible kidney transplant in Turkey, the first blood type incompatible kidney transplant, the first kidney-pancreas transplant program and the first cadaveric donor and live donor liver transplant in Antalya. Dr. As of August 2016, Alper Demirbaş has performed 4900 kidney transplants, 500 liver transplants and 95 pancreas transplants.

In addition to being the chairman of 6 national congresses, he has also been an invited speaker at 12 international and 65 national scientific congresses. Dr. Alper Demirbaş was married and the father of 1 girl and 1 boy.

Awards:

Eczacibasi Medical Award of 2002, Akdeniz University Service Award of 2005, Izder Medical Man of the Year Award of 2006, BÖHAK Medical Man of the Year Award of 2007, Sabah Mediterranean Newspaper Scientist of the Year Award of 2007, ANTIKAD Scientist of the Year Award of 2009, Social Ethics Association Award of 2010, Işık University Medical Man of the Year Award of 2015, VTV Antalya's Brand Value Award of 2015.

Certificates:

Doctor of Medicine Degree Hacettepe University Faculty of Medicine Ankara, General Surgeon Ministry of Health Turkey EKFMG (0-477-343-8), University of Miami School of Medicine Member of Multiple Organ Transplant, ASTS Multiorgan Transplant Scholarship. Lecturer at Kyoto University. Lecturer at University of Essen, Research assistant at the University of Cambridge .

Professional Members:

American Society of Transplant Surgeons, American Transplantation Society Nominated, Middle East and Southern Africa Council Transplantation Society 2007, International Liver Transplantation Association, Turkish Transplantation Association, Turkish Society of Surgery, Turkish Hepatobiliary Surgery Association.

Disclaimer:

Our website contents consist of articles approved by our Web and Medical Editorial Board with the contributions of our physicians. Our contents are prepared only for informational purposes for public benefit. Be sure to consult your doctor for diagnosis and treatment.
Medically Reviewed by Professor Doctor Alper Demirbaş
Follow me
Latest posts by Medically Reviewed by Professor Doctor Alper Demirbaş (see all)